发明名称 IDENTIFICATION, SELECTION AND USE OF HIGH CURATIVE POTENTIAL T CELL EPITOPES
摘要 A method for identifying T-cell epitopes which can be used to elicit T cells targeting cells capable of regenerating cancers is disclosed. The method identifies T-cell epitopes with a high curative potential, high potency and high probability of T cell recognition (HP). The method includes: (i) identifying high curative potential tumor protein target i.e., identifying HP-TP; (ii) identifying peptide sequences within the protein sequence of an HP-TP that have a high probability of eliciting T cell killing; and (iii) qualifying the sequence specificity based on the fold difference between the specific target and non-targets. The identified T-cell epitopes include a core sequence of 9 amino acids homologous to a sequence expressed within a qualified HP-TP. The T-cell epitopes can be used in a method for reprogramming T cells to selectively attack tumor cells capable of perpetuating a tumor and treating patients, for example, cancer patients.
申请公布号 US2016161486(A1) 申请公布日期 2016.06.09
申请号 US201514958780 申请日期 2015.12.03
申请人 Verik Bio, Inc. 发明人 Parenteau Nancy;Laning Joseph;Young Janet
分类号 G01N33/569;C07K14/47;A61K35/17 主分类号 G01N33/569
代理机构 代理人
主权项 1. A method for identifying T-cell epitopes which target cells capable of regenerating cancers comprising: (i) identifying high curative potential tumor protein targets (HP-TP) or auxiliary tumor protein targets (Aux-TP); (ii) identifying peptide sequences within the protein sequence of an HP-TP or Aux-TP that have a high probability of eliciting T cell killing; and (iii) qualifying the sequence specificity based on the fold difference between the specific target and non-targets.
地址 Southborough MA US